J.G.Chemicals Ltd
J.G.Chemicals Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #38 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
Company expects continued demand momentum throughout the year driven by strong domestic manufacturing and multiple end-user industries (tire, ceramics, pharma, specialty chemicals, agriculture). Company targets volume growth in mid-teens for the current year, supported by capacity ramp-up and new product launches.
From J.G.Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Company expects continued demand momentum throughout the year driven by strong domestic manufacturing and multiple end-user industries (tire, ceramics, pharma, specialty chemicals, agriculture).
- Volume growth was in mid-teens in the recent quarter and is expected to sustain with further ramp-up of existing capacities.
- New Gujarat (Dahej) plant to be commissioned in November 2026; targets 50-60% utilization in FY27 and 70-80% by FY28, adding 15,000 to 17,000 tons p.a. zinc oxide capacity.
- Expanded capacities and capacity improvements expected to drive double-digit volume growth in the near term.
- Higher share of value-added and specialized products (like zinc sulphate, ZRA, Lab Pure) will contribute to both volume and value growth.
2 more points from J.G.Chemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what J.G.Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- A new greenfield plant in Dahej, Gujarat, with Phase 1 capacity of 15,000 to 18,000 tons per annum, expected to be commissioned by November 2026 (Q3 FY27).
- Ramp-up plan for Dahej plant: 50%-60% utilization in FY28, aiming for 70%-80% in FY29, followed by Phase 2 expansion.
- Dahej plant's revenue potential: INR 300-400 crores with EBITDA margins expected at 11%-12%.
- Capex payback target: 3 to 4 years with expected ROCE in the mid-20% range.
- Naidupeta plant is undergoing debottlenecking to add about 5,000 tons capacity; capex details to be confirmed.
2 more points from J.G.Chemicals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what J.G.Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Strong demand momentum is highlighted across end-user applications, contributing to record quarterly sales.
- The company indicates continued strong customer demand with utilization around 80% and potential to ramp up to full capacity.
- New capacity expansions (Naidupeta debottlenecking and Dahej plant) are planned to meet increasing demand.
- The company expects higher sales and volume growth to continue through FY27 and beyond.
2 more points from J.G.Chemicals Ltd's call on order book
Create a free account to keep reading this call
J.G.Chemicals Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹286 Cr, net profit ₹19 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What J.G.Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
J.G.Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were J.G.Chemicals Ltd Q1 FY27 results?
Company expects continued demand momentum throughout the year driven by strong domestic manufacturing and multiple end-user industries (tire, ceramics, pharma, specialty chemicals, agriculture). Company targets volume growth in mid-teens for the current year, supported by capacity ramp-up and new product launches.
What is J.G.Chemicals Ltd share price analysis?
J.G.Chemicals Ltd currently shows a below-average growth signal. The stock trades at a P/E of 33.3 with a market cap of ₹2,501 Cr. Investors should review the full earnings analysis for detailed insights.
Is J.G.Chemicals Ltd planning capital expenditure?
A new greenfield plant in Dahej, Gujarat, with Phase 1 capacity of 15,000 to 18,000 tons per annum, expected to be commissioned by November 2026 (Q3 FY27).
Keep J.G.Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.